Most Recent
The Full Court has denied a request by Sanofi that it review a judge's refusal to block Alphapharm from listing its Semglee insulin injector pen on the PBS, calling the pharmaceutical giant's appeal "misconceived".
Luxury boutique retailer Watches of Switzerland has reached a settlement in principle with Transport for NSW to resolve its case alleging damages resulting from Sydney's light rail project, a court has heard.
A judge has gutted Buzzfeed's truth defence in a defamation case brought by Labor MP Emma Husar accusing the news publisher of "slut shaming" her, saying the claims said to back the defence were "incapable" of supporting its case.
Property listing rivals REA Group and Domain have settled a trade mark lawsuit over an agreement between Domain and the owner of US website realestate.com to redirect Australian traffic to Domain's website.
Media organisations ABC and Fairfax have argued that a judge's definition of espionage was "artificially narrow" when striking out their truth defence to a defamation case brought by Chinese philanthropist Dr Chau Chak Wing.
The Full Federal Court will issue its judgment Friday in French pharmaceutical giant Sanofi's challenge to a judge's refusal to block Alphapharm from listing an insulin injector pen on the PBS, just two weeks after the court heard arguments in the appeal.
Pharmaceutical giant Allergan has streamlined its trade mark case against Self Care Corporation, which makes products marketed as Botox alternatives.
Canadian generic manufacturer Apotex has agreed to drop its lawsuit against India's Cipla seeking to invalidate its Australian patent for popular nasal spray Dymista.
Motorola has accused rival Hytera Communications of a "deliberate strategy" of filing late affidavits to throw Motorola off in an already highly contentious patent and copyright case over digital radio devices.
Mylan has appealed a ruling invaliding claims of its cholesterol drug patent and dismissing its patent infringement case against Sun Pharma.